GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clinica Baviera SA (FRA:D9Z) » Definitions » Debt-to-Equity

Clinica Baviera (FRA:D9Z) Debt-to-Equity : 0.73 (As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Clinica Baviera Debt-to-Equity?

Clinica Baviera's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €0.0 Mil. Clinica Baviera's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €61.5 Mil. Clinica Baviera's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €83.8 Mil. Clinica Baviera's debt to equity for the quarter that ended in Sep. 2024 was 0.73.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Clinica Baviera's Debt-to-Equity or its related term are showing as below:

FRA:D9Z' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02   Med: 0.73   Max: 2.09
Current: 0.73

During the past 13 years, the highest Debt-to-Equity Ratio of Clinica Baviera was 2.09. The lowest was 0.02. And the median was 0.73.

FRA:D9Z's Debt-to-Equity is ranked worse than
75.39% of 191 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.27 vs FRA:D9Z: 0.73

Clinica Baviera Debt-to-Equity Historical Data

The historical data trend for Clinica Baviera's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinica Baviera Debt-to-Equity Chart

Clinica Baviera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.75 1.23 0.94 0.71 0.52

Clinica Baviera Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.52 0.45 0.02 0.73

Competitive Comparison of Clinica Baviera's Debt-to-Equity

For the Diagnostics & Research subindustry, Clinica Baviera's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinica Baviera's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Clinica Baviera's Debt-to-Equity falls into.



Clinica Baviera Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Clinica Baviera's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Clinica Baviera's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clinica Baviera  (FRA:D9Z) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Clinica Baviera Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Clinica Baviera's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinica Baviera Business Description

Traded in Other Exchanges
Address
Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.

Clinica Baviera Headlines

No Headlines